James Talbot

3.3k total citations
86 papers, 2.4k citations indexed

About

James Talbot is a scholar working on Epidemiology, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, James Talbot has authored 86 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Epidemiology, 30 papers in Infectious Diseases and 17 papers in Public Health, Environmental and Occupational Health. Recurrent topics in James Talbot's work include Pneumonia and Respiratory Infections (20 papers), Respiratory viral infections research (12 papers) and Streptococcal Infections and Treatments (9 papers). James Talbot is often cited by papers focused on Pneumonia and Respiratory Infections (20 papers), Respiratory viral infections research (12 papers) and Streptococcal Infections and Treatments (9 papers). James Talbot collaborates with scholars based in Canada, United Kingdom and United States. James Talbot's co-authors include Marguerite Lovgren, Allison McGeer, Donald E. Low, Robert S. Hodges, Robert Rennie, Benjamin Schwartz, Anna Norrby‐Teglund, Richard Long, Malak Kotb and Rupert Kaul and has published in prestigious journals such as Nature, Accounts of Chemical Research and PLoS ONE.

In The Last Decade

James Talbot

84 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Talbot Canada 28 1.0k 802 782 436 257 86 2.4k
Raúl Istúriz United States 28 1.3k 1.3× 766 1.0× 376 0.5× 310 0.7× 162 0.6× 77 2.4k
Pasquale Pagliano Italy 28 765 0.7× 886 1.1× 440 0.6× 498 1.1× 298 1.2× 102 2.7k
Magnús Gottfreðsson Iceland 29 1.4k 1.4× 1.3k 1.6× 547 0.7× 205 0.5× 327 1.3× 113 3.0k
Nevio Cimolai Canada 24 475 0.5× 684 0.9× 272 0.3× 300 0.7× 202 0.8× 118 1.8k
André Fleer Netherlands 29 1.4k 1.3× 485 0.6× 648 0.8× 293 0.7× 291 1.1× 51 2.5k
Mirjana Nesin United States 27 745 0.7× 489 0.6× 539 0.7× 186 0.4× 268 1.0× 54 1.8k
Tsuyoshi Nagatake Japan 30 1.2k 1.1× 841 1.0× 490 0.6× 454 1.0× 343 1.3× 147 2.9k
Kathryn J. Ray United States 29 571 0.5× 412 0.5× 677 0.9× 480 1.1× 317 1.2× 59 2.4k
Joseph M. Campos United States 30 736 0.7× 697 0.9× 497 0.6× 235 0.5× 482 1.9× 89 2.3k
Edwin Swiatlo United States 27 1.3k 1.2× 389 0.5× 422 0.5× 623 1.4× 763 3.0× 67 2.5k

Countries citing papers authored by James Talbot

Since Specialization
Citations

This map shows the geographic impact of James Talbot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Talbot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Talbot more than expected).

Fields of papers citing papers by James Talbot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Talbot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Talbot. The network helps show where James Talbot may publish in the future.

Co-authorship network of co-authors of James Talbot

This figure shows the co-authorship network connecting the top 25 collaborators of James Talbot. A scholar is included among the top collaborators of James Talbot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Talbot. James Talbot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Tree, Alison, Nandita M. deSouza, Annie Gao, et al.. (2022). Standard and Hypofractionated Dose Escalation to Intraprostatic Tumor Nodules in Localized Prostate Cancer: 5-Year Efficacy and Toxicity in the DELINEATE Trial. International Journal of Radiation Oncology*Biology*Physics. 115(2). 305–316. 30 indexed citations
5.
Martin, Leah J., et al.. (2019). Predicting influenza-like illness-related emergency department visits by modelling spatio-temporal syndromic surveillance data. Epidemiology and Infection. 147. e312–e312. 6 indexed citations
6.
Coates, Christopher J. & James Talbot. (2018). Hemocyanin-derived phenoloxidase reaction products display anti-infective properties. Developmental & Comparative Immunology. 86. 47–51. 35 indexed citations
7.
Fullam, Elizabeth, James Talbot, Isaac M. Westwood, et al.. (2013). Design, synthesis and structure–activity relationships of 3,5-diaryl-1H-pyrazoles as inhibitors of arylamine N-acetyltransferase. Bioorganic & Medicinal Chemistry Letters. 23(9). 2759–2764. 21 indexed citations
8.
Buxton, Jane A., et al.. (2009). Levamisole tainted cocaine causing severe neutropenia in Alberta and British Columbia. Harm Reduction Journal. 6(1). 30–30. 68 indexed citations
9.
Honish, Lance, et al.. (2007). Case series descriptive analysis of a primary syphilis outbreak in Edmonton, Alberta, July 2004-April 2006.. PubMed. 33(6). 61–7. 4 indexed citations
10.
Long, Richard, et al.. (2003). Relative Versus Absolute Noncontagiousness of Respiratory Tuberculosis on Treatment. Infection Control and Hospital Epidemiology. 24(11). 831–838. 20 indexed citations
11.
Grimsrud, Karen, et al.. (2002). Susceptibility of human isolates of Salmonella typhimurium DT 104 to antimicrobial agents used in human and veterinary medicine. Diagnostic Microbiology and Infectious Disease. 42(1). 17–20. 6 indexed citations
13.
Fábio, José Luis Di, Elizabeth Castañeda, Clara Inés Agudelo, et al.. (2001). Evolution of S treptococcus pneumoniae serotypes and penicillin susceptibility in Latin America, Sireva-Vigía Group, 1993 to 1999. The Pediatric Infectious Disease Journal. 20(10). 959–967. 93 indexed citations
14.
McGeer, Allison, et al.. (1999). Assessing the Potential Impact of Vaccination Programs on Invasive Pneumococcal Disease: Data from Population‐Based Surveillance. Canadian Journal of Infectious Diseases and Medical Microbiology. 10(A). 8 indexed citations
15.
Long, Richard, et al.. (1999). Transcontinental Spread of Multidrug-resistant Mycobacterium bovis. American Journal of Respiratory and Critical Care Medicine. 159(6). 2014–2017. 30 indexed citations
16.
Kaul, Rupert, Allison McGeer, Anna Norrby‐Teglund, et al.. (1999). Intravenous Immunoglobulin Therapy for Streptococcal Toxic Shock Syndrome—A Comparative Observational Study. Clinical Infectious Diseases. 28(4). 800–807. 343 indexed citations
17.
Shafran, Stephen D., James Talbot, Joel Singer, et al.. (1998). Does In Vitro Susceptibility to Rifabutin and Ethambutol Predict the Response to Treatment of Mycobacterium avium Complex Bacteremia with Rifabutin, Ethambutol, and Clarithromycin?. Clinical Infectious Diseases. 27(6). 1401–1405. 16 indexed citations
18.
Kertesz, Daniel A., José Luis Di Fábio, Maria Cristina de Cunto Brandileone, et al.. (1998). Invasive Streptococcus pneumoniae Infection in Latin American Children: Results of the Pan American Health Organization Surveillance Study. Clinical Infectious Diseases. 26(6). 1355–1361. 87 indexed citations
19.
Davies, H. Dele, Anne Matlow, S R Scriver, et al.. (1994). Apparent lower rates of streptococcal toxic shock syndrome and lower mortality in children with invasive Group A streptococcal infections compared with adults. The Pediatric Infectious Disease Journal. 13(1). 49–55. 53 indexed citations
20.
Talbot, James, Klaus Nielsen, & Lynette B. Corbeil. (1991). Cleavage of proteins of reproductive secretions by extracellular proteinases of Tritrichomonas foetus. Canadian Journal of Microbiology. 37(5). 384–390. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026